Barthélemy NR, Bateman RJ, Hirtz C, Marin P, Becher F, Sato C, Gabelle A, Lehmann S.

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification.

Alzheimers Res Ther. 2020 Mar 17;12(1):26. doi:10.1186/s13195-020-00596-4. PubMed PMID: 32183883